Total Payments
$2,069
2024 Payments
$442.12
Companies
14
Transactions
83
Medicare Patients
8,316
Medicare Billing
$738,868
Payment Breakdown by Category
Food & Beverage$1,704 (82.3%)
Education$365.50 (17.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,704 | 75 | 82.3% |
| Education | $365.50 | 8 | 17.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $576.64 | 28 | $0 (2023) |
| PFIZER INC. | $255.28 | 12 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $225.22 | 9 | $0 (2024) |
| UROVANT SCIENCES INC | $218.77 | 7 | $0 (2022) |
| Cook Medical LLC | $212.51 | 5 | $0 (2024) |
| Myovant Sciences Inc. | $138.55 | 3 | $0 (2022) |
| 180 Medical, Inc. | $97.13 | 4 | $0 (2024) |
| ABBVIE INC. | $83.20 | 4 | $0 (2024) |
| Boston Scientific Corporation | $65.50 | 3 | $0 (2024) |
| Medtronic, Inc. | $61.03 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $442.12 | 14 | Cook Medical LLC ($153.60) |
| 2023 | $501.89 | 21 | Astellas Pharma US Inc ($133.33) |
| 2022 | $387.17 | 13 | UROVANT SCIENCES INC ($181.64) |
| 2021 | $159.82 | 9 | Astellas Pharma US Inc ($78.72) |
| 2020 | $47.20 | 3 | Astellas Pharma US Inc ($33.72) |
| 2019 | $146.96 | 12 | Astellas Pharma US Inc ($120.24) |
| 2018 | $140.49 | 5 | Astellas Pharma US Inc ($74.39) |
| 2017 | $243.79 | 6 | Astellas Pharma US Inc ($110.67) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: HORMONE THERAPY | ||||||
| 11/22/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Cook Medical LLC | COOK (Device) | Food and Beverage | Cash or cash equivalent | $31.43 | General |
| Category: Urology | ||||||
| 09/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: HORMONE THERAPY | ||||||
| 08/27/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Advantage_URO | ||||||
| 08/27/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Advantage_URO | ||||||
| 06/06/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Advantage_URO | ||||||
| 05/04/2024 | Cook Medical LLC | LITHO 150 (Device) | Food and Beverage | Cash or cash equivalent | $122.17 | General |
| Category: Urology | ||||||
| 04/16/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.92 | General |
| 03/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: UROLOGY | ||||||
| 12/19/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Biological | ||||||
| 11/22/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2023 | Cook Medical LLC | FIBER DUST (Device) | Food and Beverage | Cash or cash equivalent | $28.27 | General |
| Category: Urology | ||||||
| 10/11/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Urology | ||||||
| 09/12/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.09 | General |
| 06/13/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Continence Care | ||||||
| 05/19/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: UROLOGY | ||||||
| 05/05/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: HORMONE THERAPY | ||||||
| 05/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,084 | 35,082 | $786,316 | $163,857 |
| 2022 | 14 | 2,069 | 95,344 | $958,037 | $181,820 |
| 2021 | 16 | 1,946 | 85,863 | $883,174 | $192,587 |
| 2020 | 18 | 2,217 | 87,254 | $791,021 | $200,604 |
Total Patients
8,316
Total Services
303,543
Medicare Billing
$738,868
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 447 | 609 | $130,417 | $40,228 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 437 | $132,229 | $36,809 | 27.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 224 | $282,464 | $30,121 | 10.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 72 | 80 | $45,590 | $14,212 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 91 | 91 | $24,123 | $7,444 | 30.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 159 | 171 | $22,847 | $7,264 | 31.8% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $22,295 | $7,231 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $18,960 | $4,913 | 25.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 236 | $14,160 | $2,424 | 17.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 345 | 550 | $7,900 | $2,163 | 27.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $10,410 | $2,005 | 19.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 15 | $4,742 | $1,367 | 28.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 30 | $6,120 | $1,264 | 20.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 17 | 18 | $8,342 | $1,117 | 13.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 27 | 50 | $4,000 | $1,114 | 27.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 114 | 133 | $6,612 | $1,034 | 15.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 205 | 268 | $2,919 | $913.88 | 31.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $2,437 | $789.46 | 32.4% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 19 | 32,000 | $32,000 | $649.96 | 2.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 20 | 20 | $6,620 | $458.08 | 6.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 16 | $825.01 | $252.15 | 30.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 38 | $304.00 | $83.60 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 540 | 863 | $270,283 | $77,802 | 28.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 29 | 285 | $359,385 | $40,765 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 238 | 286 | $63,485 | $18,373 | 28.9% |
About Dr. Robert Ryan, MD
Dr. Robert Ryan, MD is a Urology healthcare provider based in Seguin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780764258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ryan, MD has received a total of $2,069 in payments from pharmaceutical and medical device companies, with $442.12 received in 2024. These payments were reported across 83 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,704).
As a Medicare-enrolled provider, Ryan has provided services to 8,316 Medicare beneficiaries, totaling 303,543 services with total Medicare billing of $738,868. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Seguin, TX
- Active Since 10/17/2006
- Last Updated 06/18/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1780764258
Products in Payments
- GEMTESA (Drug) $320.47
- XTANDI (Drug) $289.22
- ORGOVYX (Drug) $262.07
- MYRBETRIQ (Drug) $221.14
- LITHO 150 (Device) $122.17
- Advantage System (Device) $65.50
- Myrbetriq (Drug) $65.16
- BOTOX (Biological) $62.39
- INTERSTIM (Device) $61.03
- Trulance (Drug) $54.69
- SpeediCath (Device) $42.00
- COOK (Device) $31.43
- FIBER DUST (Device) $28.27
- LUPRON DEPOT (Drug) $20.81
- Veozah (Drug) $19.46
- RESONANCE (Device) $18.55
- Cook Medical Wire Guides (Device) $13.01
- Cook Medical Stents (Device) $12.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.